<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>id000042</Identifier>
    <IdentifierDoi>10.3205/id000042</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-id0000420</IdentifierUrn>
    <ArticleType>Review Article</ArticleType>
    <TitleGroup>
      <Title language="en">Rhodotorula spp. in the gut &#8211; foe or friend&#63;</Title>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Hof</Lastname>
          <LastnameHeading>Hof</LastnameHeading>
          <Firstname>Herbert</Firstname>
          <Initials>H</Initials>
          <AcademicTitle>Prof. Dr.</AcademicTitle>
        </PersonNames>
        <Address>MVZ Labor Limbach und Kollegen, Im Breitspiel 16, 69126 Heidelberg<Affiliation>MVZ Labor Limbach und Kollegen</Affiliation></Address>
        <Email>herbert.hof&#64;labor-limbach.de</Email>
        <Creatorrole corresponding="yes" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
      <Keyword language="en">mycobiome</Keyword>
      <Keyword language="en">fluconazole resistant</Keyword>
      <Keyword language="en">gut</Keyword>
      <Keyword language="en">Rhodotorula</Keyword>
      <Keyword language="en">basidiomyceteous yeast</Keyword>
      <Keyword language="en">oleagenous yeast</Keyword>
      <Keyword language="en">carotinoids</Keyword>
      <Keyword language="de">Mycobiom</Keyword>
      <Keyword language="de">Darm</Keyword>
      <Keyword language="de">Rhodotorula</Keyword>
      <Keyword language="de">basidiomyetische Spro&#223;pilze</Keyword>
      <Keyword language="de">&#246;lhaltige Spro&#223;pilze</Keyword>
      <Keyword language="de">Karotinoide</Keyword>
    </SubjectGroup>
    <DatePublishedList>
      
    <DatePublished>20190902</DatePublished></DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Journal>
        <ISSN>2195-8831</ISSN>
        <Volume>7</Volume>
        <JournalTitle>GMS Infectious Diseases</JournalTitle>
        <JournalTitleAbbr>GMS Infect Dis</JournalTitleAbbr>
      </Journal>
    </SourceGroup>
    <ArticleNo>02</ArticleNo>
  </MetaData>
  <OrigData>
    <Abstract language="en" linked="yes"><Pgraph><Mark2>Rhodotorula</Mark2> spp. belong to the basidiomyceteous fungi. They are widespread in the environment. Transmission to humans occur mainly through air and food. Intestinal colonization is rather common, but an overgrowth is normally suppressed, since their optimal growth temperature is exceeded in the body. A massive presence in the gut indicates a disturbance of the balance of the microbial flora due to different causes. One particular reason will be the treatment with azoles because this will create an advantage for these azole resistant fungi. First of all, the finding of increased numbers of <Mark2>Rhodotorula</Mark2> in stool specimen is not alarming. In contrast, the colonized human will profit from such a situation since these fungi produce a lot of useful nutrients such as proteins, lipids, folate, and carotinoids. Furthermore, a probiotic effect due to regulation of multiplication of pathogenic bacteria and by neutralizing or destroying their toxins can be anticipated. On the other hand, their massive presence may increase the risk of fungemia and ensuing organ infections especially when the host defense system is hampered. Indeed, <Mark2>Rhodotorula</Mark2> spp. range among the emerging fungal pathogens in the compromised host. However, it can be doubted whether all these opportunistic infections reported originate primarily from the gut.</Pgraph></Abstract>
    <TextBlock linked="yes" name="Introduction">
      <MainHeadline>Introduction</MainHeadline><Pgraph>The mycobiome in the human intestinal tract consists of a plethora of various genera and species <TextLink reference="1"></TextLink>, among them are moulds as well as yeasts. The role of the various moulds remains largely unknown yet whereby the yeast population has gained much more interest until now. Especially the pathogenic role of intestinal <Mark2>Candida</Mark2> spp. and <Mark2>Saccharomyces</Mark2> spp. has been discussed extensively <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink> whereas the relevance of <Mark2>Rhodotorula</Mark2> spp. is hardly acknowleged although they are often found in stool specimen of humans <TextLink reference="1"></TextLink>, <TextLink reference="4"></TextLink>. Intestinal colonization in healthy children is found in up to 5&#37; and in young adults even in 12&#37; <TextLink reference="5"></TextLink>. Then again, these yeasts have been declared as emerging pathogens inducing fungemia <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink> often associated with central catheters <TextLink reference="8"></TextLink> and even solid organ infections such as  endogenous endophthalmitis <TextLink reference="10"></TextLink>. </Pgraph></TextBlock>
    <TextBlock linked="yes" name="Biology">
      <MainHeadline>Biology</MainHeadline><Pgraph>In contrast to the ascomycetous yeasts such as <Mark2>Saccharomyces</Mark2> spp. and <Mark2>Candida</Mark2> spp., <Mark2>Rhodotorula</Mark2> spp. belong to the vast phylum of basidiomycetes namely to the family of  Sporidiobolales. Typically, <Mark2>Rhodotorula</Mark2> spp. produce carotinoids which cause pink to red colonies on agar (Figure 1 <ImgLink imgNo="1" imgType="figure"/>). (One should be aware that the red colonies of the bacterium Serratia marcescens are due to the pigment prodigiosin). Furthermore, they belong to the oleaginous yeasts characterized by the fact that up to 50&#37; of their dry weight consist of lipids <TextLink reference="11"></TextLink>. The optimal temperature for growth is between 18 and 22&#176;C. In vitro, the growth is reduced at temperatures &#62;33&#176;C <TextLink reference="12"></TextLink>, <TextLink reference="13"></TextLink>. The fungus produces unicellular blastoconidia but does not generate pseudohyphae or even hyphae.</Pgraph><Pgraph>Actually, there are 8 species of the genus <Mark2>Rhodotorula</Mark2> known and several of them are found in humans for example <Mark2>R. glutinis</Mark2>, <Mark2>R. minuta</Mark2>, and <Mark2>R. mucilaginosa</Mark2>. Since these fungi are tolerant to dryness, they are able to survive in the environment <TextLink reference="12"></TextLink>. Hence, this genus can be found almost everywhere in the surroundings, namely in the air &#8211; <Mark2>Rhodotorula</Mark2> is one of the most common fungi transmitted by air  &#8211; in soil and water, namely ocean seas as well as lakes, in many kinds of fruits and berries (for example strawberries), milk, toothbrushes and shower curtains. Since these yeasts are endowed with a definite affinity for plastic materials <TextLink reference="8"></TextLink>, they can be often detected in medical devices, for example on plastic catheters <TextLink reference="14"></TextLink>, <TextLink reference="15"></TextLink> and dental equipments <TextLink reference="16"></TextLink> where they will grow in form of biofilms <TextLink reference="17"></TextLink>. Furthermore, they colonize often hands of medical staff <TextLink reference="8"></TextLink>, <TextLink reference="18"></TextLink>.</Pgraph><Pgraph>Obviously, they are taken up regularly by mammals as well as humans via food, which may lead to intermittent or even permanent gut colonization even in healthy subjects <TextLink reference="1"></TextLink>, <TextLink reference="5"></TextLink>, <TextLink reference="19"></TextLink> not least because they are relatively resistant to bile <TextLink reference="12"></TextLink> in comparison to <Mark2>Candida albicans</Mark2> being susceptible to bile acids to some extent <TextLink reference="20"></TextLink>.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Antimycotic susceptibilities">
      <MainHeadline>Antimycotic susceptibilities</MainHeadline><Pgraph>Amphotericin B is the most active agent <TextLink reference="9"></TextLink>. Furthermore, synergisms between amphotericin B and various non-antifungals have been reported <TextLink reference="21"></TextLink>. Flucytosine is also reliably active (Table 1 <ImgLink imgNo="1" imgType="table"/>).  In general, however, isolates of <Mark2>Rhodotorula</Mark2> spp. are resistant to fluconazole and only poorly susceptible to posaconazole and voriconazole <TextLink reference="17"></TextLink>, <TextLink reference="18"></TextLink>, <TextLink reference="22"></TextLink>, <TextLink reference="23"></TextLink>, <TextLink reference="24"></TextLink>. Consequently, these yeasts have a chance to be selected especially in a clinical setting in patients under a longlasting therapeutic regimen with azoles, i.e. fluconazole or posaconazole <TextLink reference="25"></TextLink>. Since <Mark2>Rhodotorula</Mark2> spp. belong to the basidiomycetes, which quite typically do not contain1-3-&#946;-glucan in their cell wall, they are intrinsically resistant to echinocandins. Hence, colonizations and even breakthrough infections are also reported in patients treated with echinocandins <TextLink reference="15"></TextLink>.</Pgraph><Pgraph></Pgraph></TextBlock>
    <TextBlock linked="yes" name="Detrimental effects (foe)">
      <MainHeadline>Detrimental effects (foe)</MainHeadline><SubHeadline>Metabolic disturbances</SubHeadline><Pgraph>At least in vitro, <Mark2>Rhodotorula</Mark2> spp. like many other oleaginous fungi are enabled to metabolize avidly short-chain fatty acids such as acetic, propionic and butyric acid <TextLink reference="26"></TextLink>. Therefore, it could be expected that a massive presence of <Mark2>Rhodotorula</Mark2> spp. in the gut could lead to a shortage of those bacterial products. A loss of their beneficial functions, i.e. their anti-inflammatory, anti-oxidative, anti-cancer and antibacterial effects, would be definitely a disadvantage for the host. Furthermore, these short-chain fatty acids are essential for the function of the gut epithelium, liver and brain <TextLink reference="27"></TextLink>. However, substantiated data on the influence of <Mark2>Rhodotorula</Mark2> spp. on the fatty acid metabolism and composition in the human gut are still lacking.</Pgraph><SubHeadline>Invasion</SubHeadline><Pgraph>Especially in the German literature the phenomenon of &#8220;persorption&#8221;, which means a paracellular translocation of particles and microorganisms including yeasts across the gut wall, has been discussed over centuries <TextLink reference="28"></TextLink>. However, the gut epithelium with tight junctions interconnecting the epithelial cells and restricting the passage of particles and microorganisms through the paracellular space represents a solid anatomical barrier inhibiting the unlimited passage of microorganisms. </Pgraph><Pgraph>There are three main pathophysiological groups of persons where intestinal barrier failure can be definitely observed <TextLink reference="29"></TextLink>, <TextLink reference="30"></TextLink>:</Pgraph><Pgraph><OrderedList><ListItem level="1" levelPosition="1" numString="1.">in patients undergoing abdominal surgery, </ListItem><ListItem level="1" levelPosition="2" numString="2.">in critically ill patients for example cancer patients suffering from mucositis after  cytostatic therapy, </ListItem><ListItem level="1" levelPosition="3" numString="3.">in patients with chronic pathologic conditions such as HIV infection, liver cirrhosis or inflammatory bowel disease.</ListItem></OrderedList></Pgraph><Pgraph>Hence, translocation of pathogens from the gut through a dysfunctional mucosal barrier to the mesenteric lymph nodes, the portal vein, and the systemic circulation, eventually leading to sepsis and infectious metastases in various organs, may happen. And even in healthy subjects, this may occur occasionally without any deleterious consequences. A baseline rate of 5&#8211;10&#37; of spontaneous translocation of intestinal microorganisms has been estimated to occur in humans <TextLink reference="31"></TextLink>. <Mark2>Rhodotorula</Mark2> spp. in particular have been suspected to disrupt this barrier to a certain extent <TextLink reference="32"></TextLink> presumably facilitating passage. Fungemia <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink> and organ infections <TextLink reference="10"></TextLink> due to <Mark2>Rhodotorula</Mark2> spp. have indeed been described, but it remains obscure, whether in all cases this was directly due to gut colonization <TextLink reference="8"></TextLink>. </Pgraph><Pgraph>Then again, it has been argued <TextLink reference="29"></TextLink>, <TextLink reference="31"></TextLink>, <TextLink reference="33"></TextLink>, <TextLink reference="34"></TextLink> that the exposure of the local gut immune system to microbial antigens will have favorable consequences since it may strengthen the defense system of the host in case of a massive invasion and may help to establish tolerance to antigens of commensal microflora. </Pgraph><SubHeadline>Allergy</SubHeadline><Pgraph>It has been discussed that several yeast antigens, for example mannans, mannoproteins as well as several enzymes such as enolase, in the gut may stimulate the intestinal and furthermore the systemic immune system leading to hypersensitivity against inhaled as well as ingested antigens <TextLink reference="35"></TextLink>, <TextLink reference="36"></TextLink>, <TextLink reference="37"></TextLink>, <TextLink reference="38"></TextLink>. Since <Mark2>Rhodotorula</Mark2> spp. also generate those constituents, it could be speculated that they should be able to induce the same hypersensitivities, too.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Beneficial effects (friend)">
      <MainHeadline>Beneficial effects (friend)</MainHeadline><SubHeadline>Fungal products as nutrients</SubHeadline><Pgraph><Mark2>Rhodotorula</Mark2> spp. like many other yeasts may accumulate or secrete proteins and various enzymes <TextLink reference="11"></TextLink> such as amylase, cellulase, xylanase etc. contributing to the degradation of the viscosity-generating soluble fibers in food items, considered to be nutritionally advantageous <TextLink reference="39"></TextLink>. Fungal proteases have been shown to degrade also bacterial toxins <TextLink reference="40"></TextLink>. Furthermore, <Mark2>Rhodotorula</Mark2> is a good producer of folate <TextLink reference="39"></TextLink> which is an important micronutrient for all living organisms.</Pgraph><Pgraph>In addition, these oleaginous yeasts are endowed with a particular capacity to form saturated long-chain fatty acids like oleic, linoleic, and in particular palmitic acids, which can be stored in the fungal cells, so that up to 50&#37; of the dry weight of these cells consist of lipids <TextLink reference="11"></TextLink>. It remains still obscure actually what this fact finally means for the host. Whereas the role of the bacterial part of the microbiome on the lipid metabolism has been elucidated recently <TextLink reference="41"></TextLink>, the influence of fungi and especially of oleaginous yeasts such as <Mark2>Rhodotorula</Mark2> has been ignored until now. Hence, it can only be speculated whether the saturated fatty acids represent a high calorie source ensuing a nutritional benefit or whether it may support in some cases obesity. </Pgraph><Pgraph>One characteristic trait of <Mark2>Rhodotorula</Mark2> spp. is the production of different carotinoids giving the fungal colonies their pink appearance. These fungal metabolites can be further converted into vitamin A, which by the way cannot be produced by a human host himself <TextLink reference="1"></TextLink>. This vitamin is well known for its protective effects on epithelia <TextLink reference="42"></TextLink>. Consequently, it could be expected that it may help to strengthen the intestinal barrier function protecting against bacterial translocations and infections.</Pgraph><Pgraph>By the way, in the future, recombinant strains of <Mark2>Rhodotorula</Mark2> spp. may eventually be used as living cellular carriers delivering various biologically active agents such as insulin into the gut as has been shown in animal experiments <TextLink reference="43"></TextLink>. </Pgraph><SubHeadline>Probiotic effect</SubHeadline><Pgraph><Mark2>Saccharomyces</Mark2> spp. and in particular the so-called <TextGroup><Mark2>S. c</Mark2></TextGroup><Mark2>erevisiae</Mark2> <Mark2>var. boulardii</Mark2> are used therapeutically in patients with diarrhoea caused by <Mark2>Clostridium difficile</Mark2>, enterohemorrhagic <Mark2>E. coli</Mark2> or <Mark2>Salmonella</Mark2> <TextLink reference="44"></TextLink>, <TextLink reference="45"></TextLink>. At least partially, the positive effects are due to competition with the intestinal flora <TextLink reference="40"></TextLink> and especially by binding of pathogenic bacteria or their toxins to the mannan structures in the cell surface of yeasts <TextLink reference="46"></TextLink>, <TextLink reference="47"></TextLink>. In principle, <Mark2>Rhodotorula</Mark2> spp. express similar molecules in their cell wall, and thus, it could be expected that the commensal <Mark2>Rhodotorula</Mark2> spp. also can exert similar beneficial effects. Furthermore, <Mark2>S. boulardii</Mark2> has the potential to interact with the intestinal immune system and to suppress the intestinal inflammation by inhibiting the migration of inflammatory leukocytes from the mesenteric lymph nodes <TextLink reference="44"></TextLink>. Then again, not all properties of <Mark2>S. cerevisiae</Mark2> can be replaced by <Mark2>Rhodotorula</Mark2> spp. Whereas oral feeding of mice with living <Mark2>S. cerevisiae</Mark2> stimulated the intestinal epithelium to produce purines which leads to elevated uric acid blood levels above controls, <Mark2>Rhodotorula</Mark2> did not <TextLink reference="32"></TextLink>. </Pgraph></TextBlock>
    <TextBlock linked="yes" name="Evaluation">
      <MainHeadline>Evaluation</MainHeadline><Pgraph>Although the mycobiome of the gut is numerically definitely smaller than the bacterial community, it may exert a disproportional effect on health or disease <TextLink reference="1"></TextLink>. Prolonged treatment with broad-spectrum antibiotics especially with those secreted into the gut such as ciprofloxacin and ceftriaxone can disturb the balance in favor of fungi <TextLink reference="43"></TextLink> especially of yeasts and among them <Mark2>Rhodotorula</Mark2> spp. belonging to the basidiomycetes. The additional therapy with metronidazole, eliminating the anaerobic bacteria will further enhance the fungal overgrowth <TextLink reference="48"></TextLink>. An antagonism between bacteria such <Mark2>E. coli</Mark2> and <Mark2>Rhodotorula</Mark2> in particular has been observed already long time ago <TextLink reference="12"></TextLink>. Whereas in older publications <TextLink reference="12"></TextLink> it has been reported, that <Mark2>Rhodotorula</Mark2> are cultured in stool specimen rather rarely, today yeasts of this genus are the most common yeasts in stool specimen besides <Mark2>Saccharomyces</Mark2> spp. and <Mark2>Candida</Mark2> spp. <TextLink reference="5"></TextLink>, <TextLink reference="19"></TextLink>, <TextLink reference="32"></TextLink>; indeed the numbers detected are quite considerable in some cases. It can be argued that the frequent use of fluconazole and echinocandins, respectively, for therapy and prophylaxis of yeast infections may have contributed to this fact, since <Mark2>Rhodotorula</Mark2> spp., which are intrinsically resistant to these antimycotic agents (Table 1 <ImgLink imgNo="1" imgType="table"/>),  will profit from such a selective pressure. The overgrowth of <Mark2>Rhodotorula</Mark2> spp. in the gut occurs in spite of non-favorable conditions. Because the optimal growth temperature for <Mark2>Rhodotorula</Mark2> spp. is between 28 and 22&#176;C <TextLink reference="12"></TextLink>, <TextLink reference="13"></TextLink> and the multiplication rate is limited at temperatures &#62;33&#176;C, in normal, healthy individuals the number of <Mark2>Rhodotorula</Mark2> spp. in the gut will be restricted. The fact that increased numbers of <Mark2>Rhodotorula</Mark2> spp. in stool specimen of sick patients after various medical interventions are found rather often <TextLink reference="1"></TextLink>, <TextLink reference="4"></TextLink>, <TextLink reference="8"></TextLink> indicates, however, a definite alteration of the milieu and a disturbed balance in the microbial population in the gut of those individuals. Obviously, these fungi can survive and multiply in the extreme, unfavorable conditions in the gut. A relative resistance to bile acids <TextLink reference="12"></TextLink> may facilitate the colonization.</Pgraph><Pgraph>The question here is, which role plays the fungal flora in the gut. It is well accepted that commensal, low-virulent fungi in the gut like commensal bacteria are able to induce disease at least in case that the individuals has developed a considerable degree of predisposition <TextLink reference="44"></TextLink>. </Pgraph><Pgraph>It has been argued that Candida spp. in the gut are relatively often associated with disease, whereas <Mark2>Rhodotorula</Mark2> spp. are not <TextLink reference="49"></TextLink>. Although one can assume that <Mark2>Rhodotorula</Mark2> spp. like other microorganisms in the gut may have the chance to cross a dysfunctional intestinal barrier, it remains still uncertain whether this pathway represents really the primary cause of fungemia <TextLink reference="8"></TextLink>. Indeed, it can be doubted whether the pathogens found in blood or in solid organs originate from the population found in the stool specimen, since it has to be kept in mind that the ubiquitous and saprophytic <Mark2>Rhodotorula</Mark2> spp. are transmitted rather frequently by water <TextLink reference="8"></TextLink>, <TextLink reference="50"></TextLink> and especially by air <TextLink reference="8"></TextLink>.  Hence, at least transient colonization not only of the gut but also of other sites such as the skin occurs, which might become subsequently the main source of catheter infections and ensuing fungemia. Most cases of <Mark2>Rhodotorula</Mark2> fungemia are actually associated with contaminated central catheters <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink> especially in patients with cytotoxic drugs <TextLink reference="3"></TextLink>. Potential pathogenic property of <Mark2>Rhodotorula</Mark2> spp. has long been known and experimental infections of animals are reported <TextLink reference="8"></TextLink>, <TextLink reference="51"></TextLink>. In the last 3 decades it is becoming more and more evident, that <Mark2>R. glutinis</Mark2>, <Mark2>R. minuta</Mark2> and <Mark2>R. mucilaginosa</Mark2> range among the emerging pathogens especially in immunocompromised patients provided with central venous catheters, since <Mark2>Rhodotorula</Mark2> spp. are able to settle on surfaces of implanted materials and to form biofilms there <TextLink reference="8"></TextLink>. In comparison to the high prevalence of Candida spp. in blood cultures the frequency of <Mark2>Rhodotorula</Mark2> spp., however, remains still relatively low <TextLink reference="8"></TextLink>.</Pgraph><Pgraph>Yeasts in the gut are not only innocent commensal bystanders <TextLink reference="44"></TextLink>. They may induce not only  infections, but they may trigger metabolic disturbances <TextLink reference="4"></TextLink>, <TextLink reference="19"></TextLink> and engender allergy <TextLink reference="35"></TextLink>, <TextLink reference="36"></TextLink>, <TextLink reference="37"></TextLink>, <TextLink reference="38"></TextLink>. It can be assumed that <Mark2>Rhodotorula</Mark2> spp. exert at least partially similar effects <TextLink reference="26"></TextLink>.</Pgraph><Pgraph>Then again, a host will profit to some extent from <Mark2>Rhodotorula</Mark2> spp. in his gut, since these yeast produce nutrients such as lipids, carotinoids, folate and proteins <TextLink reference="1"></TextLink>, <TextLink reference="11"></TextLink>, <TextLink reference="39"></TextLink>. In addition, fungal enzymes may help to digest vegetable food <TextLink reference="39"></TextLink>. A probiotic effect may be exerted by binding <TextLink reference="46"></TextLink>, <TextLink reference="47"></TextLink> or destroying bacterial toxins for example those from <Mark2>C. difficile</Mark2> <TextLink reference="40"></TextLink>. However, the probiotic effect of <Mark2>Rhodotorula</Mark2> may be lower than that of Saccharomyces and other ascomycetic yeasts, since <Mark2>Rhodotorula</Mark2> spp. like all basidiomycetes do not possess 1-3-&#946;-glucan in their cell wall, so that these fungi will not be able to trigger the dectin 1-receptor on the surface of macrophages. Consequently, it can be anticipated that a stimulation of the local immune system will not happen.</Pgraph><Pgraph>Now, overall <Mark2>Rhodotorula</Mark2> spp. obviously will have certain beneficial impacts on the health of colonized humans; hence an eradication is not indicated in every case. But on the other hand these opportunistic fungi are principally able to induce serious infections at least in the compromised patient. Thus, a definitive assessment whether <Mark2>Rhodotorula</Mark2> spp. are foes or friends is actually not yet possible, since the knowledge about this neglected and underestimated yeast is still incomplete. Hence, some of the above remarks will possibly not be maintained over time.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Conclusion">
      <MainHeadline>Conclusion</MainHeadline><Pgraph><Mark2>Rhodotorula</Mark2> spp. belong to the basidiomycetic fungi. They are widespread in the environment. Transmission to humans occur mainly through air and food. Intestinal colonization is rather common, but an overgrowth is normally suppressed, since their optimal growth temperature is exceeded in the body. A massive presence in the gut indicates a disturbance of the balance of the microbial flora due to different causes. One particular reason will be the treatment with azoles, because this will create an advantage for these azole resistant fungi. First of all, the finding of increased numbers of <Mark2>Rhodotorula</Mark2> in stool specimen is not alarming. In contrast, the colonized human will profit from such a situation, since these fungi produce a lot of useful nutrients such as proteins, lipids, folate and carotinoids. Furthermore, a probiotic effect due to regulation of multiplication of pathogenic bacteria ad by neutralizing or destroying their toxins can be anticipated. On the other hand, their massive presence may increase the risk of fungemia and ensuing organ infections especially when the host defense system is hampered. Indeed, <Mark2>Rhodotorula</Mark2> spp. range among the emerging fungal pathogens in the compromised host. It can be doubted, however, whether all these opportunistic infections reported originate primarily from the gut.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Notes">
      <MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>The author declares that he has no competing interests.</Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Hof H</RefAuthor>
        <RefTitle>Pilze im Darm &#8211; das Mykobiom des Darms</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Z Gastroenterol</RefJournal>
        <RefPage>772-8</RefPage>
        <RefTotal>Hof H. Pilze im Darm &#8211; das Mykobiom des Darms &#91;Fungi in the gut &#8211; the gut mycobiome&#93;. Z Gastroenterol. 2017 Aug;55(8):772-8. DOI: 10.1055&#47;s-0043-112657</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1055&#47;s-0043-112657</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Gouba N</RefAuthor>
        <RefAuthor>Drancourt M</RefAuthor>
        <RefTitle>Digestive tract mycobiota: a source of infection</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Med Mal Infect</RefJournal>
        <RefPage>9-16</RefPage>
        <RefTotal>Gouba N, Drancourt M. Digestive tract mycobiota: a source of infection. Med Mal Infect. 2015 Jan-Feb;45(1-2):9-16. DOI: 10.1016&#47;j.medmal.2015.01.007</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.medmal.2015.01.007</RefLink>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Tligui H</RefAuthor>
        <RefAuthor>Oudaina W</RefAuthor>
        <RefAuthor>El Ftouh S</RefAuthor>
        <RefAuthor>Madda F</RefAuthor>
        <RefAuthor>Hesseissen L</RefAuthor>
        <RefTitle>Une ulc&#233;ration cutan&#233;e due &#224; Rhodotorula mucilaginosa chez un enfant immunod&#233;prim&#233;</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>J Mycol Med</RefJournal>
        <RefPage>215-7</RefPage>
        <RefTotal>Tligui H, Oudaina W, El Ftouh S, Madda F, Hesseissen L. Une ulc&#233;ration cutan&#233;e due &#224; Rhodotorula mucilaginosa chez un enfant immunod&#233;prim&#233; &#91;A skin ulcer infection due to Rhodotorula mucilaginosa in an immunocompromised child&#93;. J Mycol Med. 2018 Mar;28(1):215-7. DOI: 10.1016&#47;j.mycmed.2018.01.006</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.mycmed.2018.01.006</RefLink>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>Borges FM</RefAuthor>
        <RefAuthor>de Paula TO</RefAuthor>
        <RefAuthor>Sarmiento MRA</RefAuthor>
        <RefAuthor>de Oliveira MG</RefAuthor>
        <RefAuthor>Pereira MLM</RefAuthor>
        <RefAuthor>Toledo IV</RefAuthor>
        <RefAuthor>Nascimento TC</RefAuthor>
        <RefAuthor>Ferreira-Machado AB</RefAuthor>
        <RefAuthor>Silva VL</RefAuthor>
        <RefAuthor>Diniz CG</RefAuthor>
        <RefTitle>Fungal Diversity of Human Gut Microbiota Among Eutrophic, Overweight, and Obese Individuals Based on Aerobic Culture-Dependent Approach</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Curr Microbiol</RefJournal>
        <RefPage>726-35</RefPage>
        <RefTotal>Borges FM, de Paula TO, Sarmiento MRA, de Oliveira MG, Pereira MLM, Toledo IV, Nascimento TC, Ferreira-Machado AB, Silva VL, Diniz CG. Fungal Diversity of Human Gut Microbiota Among Eutrophic, Overweight, and Obese Individuals Based on Aerobic Culture-Dependent Approach. Curr Microbiol. 2018 Jun;75(6):726-35. DOI: 10.1007&#47;s00284-018-1438-8</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00284-018-1438-8</RefLink>
      </Reference>
      <Reference refNo="19">
        <RefAuthor>Kowalewska B</RefAuthor>
        <RefAuthor>Zorena K</RefAuthor>
        <RefAuthor>Szmigiero-Kawko M</RefAuthor>
        <RefAuthor>W&#261;&#380; P</RefAuthor>
        <RefAuthor>My&#347;liwiec M</RefAuthor>
        <RefTitle>Higher diversity in fungal species discriminates children with type 1 diabetes mellitus from healthy control</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Patient Prefer Adherence</RefJournal>
        <RefPage>591-9</RefPage>
        <RefTotal>Kowalewska B, Zorena K, Szmigiero-Kawko M, W&#261;&#380; P, My&#347;liwiec M. Higher diversity in fungal species discriminates children with type 1 diabetes mellitus from healthy control. Patient Prefer Adherence. 2016;10:591-9. DOI: 10.2147&#47;PPA.S97852</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2147&#47;PPA.S97852</RefLink>
      </Reference>
      <Reference refNo="5">
        <RefAuthor>Strati F</RefAuthor>
        <RefAuthor>Di Paola M</RefAuthor>
        <RefAuthor>Stefanini I</RefAuthor>
        <RefAuthor>Albanese D</RefAuthor>
        <RefAuthor>Rizzetto L</RefAuthor>
        <RefAuthor>Lionetti P</RefAuthor>
        <RefAuthor>Calabr&#242; A</RefAuthor>
        <RefAuthor>Jousson O</RefAuthor>
        <RefAuthor>Donati C</RefAuthor>
        <RefAuthor>Cavalieri D</RefAuthor>
        <RefAuthor>De Filippo C</RefAuthor>
        <RefTitle>Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Front Microbiol</RefJournal>
        <RefPage>1227</RefPage>
        <RefTotal>Strati F, Di Paola M, Stefanini I, Albanese D, Rizzetto L, Lionetti P, Calabr&#242; A, Jousson O, Donati C, Cavalieri D, De Filippo C. Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract. Front Microbiol. 2016;7:1227. DOI: 10.3389&#47;fmicb.2016.01227</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3389&#47;fmicb.2016.01227</RefLink>
      </Reference>
      <Reference refNo="6">
        <RefAuthor>De Almeida GM</RefAuthor>
        <RefAuthor>Costa SF</RefAuthor>
        <RefAuthor>Melhem M</RefAuthor>
        <RefAuthor>Motta AL</RefAuthor>
        <RefAuthor>Szeszs MW</RefAuthor>
        <RefAuthor>Miyashita F</RefAuthor>
        <RefAuthor>Pierrotti LC</RefAuthor>
        <RefAuthor>Rossi F</RefAuthor>
        <RefAuthor>Burattini MN</RefAuthor>
        <RefTitle>Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects</RefTitle>
        <RefYear>2008</RefYear>
        <RefJournal>Med Mycol</RefJournal>
        <RefPage>547-56</RefPage>
        <RefTotal>De Almeida GM, Costa SF, Melhem M, Motta AL, Szeszs MW, Miyashita F, Pierrotti LC, Rossi F, Burattini MN. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med Mycol. 2008 Sep;46(6):547-56. DOI: 10.1080&#47;13693780801972490</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1080&#47;13693780801972490</RefLink>
      </Reference>
      <Reference refNo="7">
        <RefAuthor>Tuon FF</RefAuthor>
        <RefAuthor>Costa SF</RefAuthor>
        <RefTitle>Rhodotorula infection. A systematic review of 128 cases from literature</RefTitle>
        <RefYear>2008</RefYear>
        <RefJournal>Rev Iberoam Micol</RefJournal>
        <RefPage>135-40</RefPage>
        <RefTotal>Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol. 2008 Sep;25(3):135-40.</RefTotal>
      </Reference>
      <Reference refNo="8">
        <RefAuthor>Wirth F</RefAuthor>
        <RefAuthor>Goldani LZ</RefAuthor>
        <RefTitle>Epidemiology of Rhodotorula: an emerging pathogen</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>Interdiscip Perspect Infect Dis</RefJournal>
        <RefPage>465717</RefPage>
        <RefTotal>Wirth F, Goldani LZ. Epidemiology of Rhodotorula: an emerging pathogen. Interdiscip Perspect Infect Dis. 2012;2012:465717. DOI: 10.1155&#47;2012&#47;465717</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2012&#47;465717</RefLink>
      </Reference>
      <Reference refNo="9">
        <RefAuthor>Ioannou P</RefAuthor>
        <RefAuthor>Vamvoukaki R</RefAuthor>
        <RefAuthor>Samonis G</RefAuthor>
        <RefTitle>Rhodotorula species infections in humans: A systematic review</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Mycoses</RefJournal>
        <RefPage>90-100</RefPage>
        <RefTotal>Ioannou P, Vamvoukaki R, Samonis G. Rhodotorula species infections in humans: A systematic review. Mycoses. 2019 Feb;62(2):90-100. DOI: 10.1111&#47;myc.12856</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;myc.12856</RefLink>
      </Reference>
      <Reference refNo="10">
        <RefAuthor>Luong PM</RefAuthor>
        <RefAuthor>Kalpakian B</RefAuthor>
        <RefAuthor>Jaeger LJ</RefAuthor>
        <RefAuthor>Lahey T</RefAuthor>
        <RefAuthor>Chapman CB</RefAuthor>
        <RefAuthor>Zegans ME</RefAuthor>
        <RefTitle>Endogenous Endophthalmitis: A Novel Harbinger of the Injection Drug Epidemic in the United States</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Case Rep Infect Dis</RefJournal>
        <RefPage>9686353</RefPage>
        <RefTotal>Luong PM, Kalpakian B, Jaeger LJ, Lahey T, Chapman CB, Zegans ME.  Endogenous Endophthalmitis: A Novel Harbinger of the Injection Drug Epidemic in the United States. Case Rep Infect Dis. 2017;2017:9686353. DOI: 10.1155&#47;2017&#47;9686353</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2017&#47;9686353</RefLink>
      </Reference>
      <Reference refNo="11">
        <RefAuthor>Xue SJ</RefAuthor>
        <RefAuthor>Chi Z</RefAuthor>
        <RefAuthor>Zhang Y</RefAuthor>
        <RefAuthor>Li YF</RefAuthor>
        <RefAuthor>Liu GL</RefAuthor>
        <RefAuthor>Jiang H</RefAuthor>
        <RefAuthor>Hu Z</RefAuthor>
        <RefAuthor>Chi ZM</RefAuthor>
        <RefTitle>Fatty acids from oleaginous yeasts and yeast-like fungi and their potential applications</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Crit Rev Biotechnol</RefJournal>
        <RefPage>1049-60</RefPage>
        <RefTotal>Xue SJ, Chi Z, Zhang Y, Li YF, Liu GL, Jiang H, Hu Z, Chi ZM. Fatty acids from oleaginous yeasts and yeast-like fungi and their potential applications. Crit Rev Biotechnol. 2018 Nov;38(7):1049-60. DOI: 10.1080&#47;07388551.2018.1428167</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1080&#47;07388551.2018.1428167</RefLink>
      </Reference>
      <Reference refNo="12">
        <RefAuthor>Staib F</RefAuthor>
        <RefTitle>Rhodotorula, ihr Vorkommen im menschlichen K&#246;rper</RefTitle>
        <RefYear>1956</RefYear>
        <RefJournal>Zbl Bakt I Abt Orig</RefJournal>
        <RefPage>86-93</RefPage>
        <RefTotal>Staib F. Rhodotorula, ihr Vorkommen im menschlichen K&#246;rper. Zbl Bakt I Abt Orig. 1956;167:86-93.</RefTotal>
      </Reference>
      <Reference refNo="13">
        <RefAuthor>Staib F</RefAuthor>
        <RefTitle>Rhodotorula in der Galle des Menschen</RefTitle>
        <RefYear>1958</RefYear>
        <RefJournal>Zbl Bakt I Abt Orig</RefJournal>
        <RefPage>142-6</RefPage>
        <RefTotal>Staib F. Rhodotorula in der Galle des Menschen. Zbl Bakt I Abt Orig. 1958;172:142-6.</RefTotal>
      </Reference>
      <Reference refNo="14">
        <RefAuthor>Kitazawa T</RefAuthor>
        <RefAuthor>Ishigaki S</RefAuthor>
        <RefAuthor>Seo K</RefAuthor>
        <RefAuthor>Yoshino Y</RefAuthor>
        <RefAuthor>Ota Y</RefAuthor>
        <RefTitle>Catheter-related bloodstream infection due to Rhodotorula mucilaginosa with normal serum (1&#8594;3)-&#946;-D-glucan level</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>J Mycol Med</RefJournal>
        <RefPage>393-5</RefPage>
        <RefTotal>Kitazawa T, Ishigaki S, Seo K, Yoshino Y, Ota Y. Catheter-related bloodstream infection due to Rhodotorula mucilaginosa with normal serum (1&#8594;3)-&#946;-D-glucan level. J Mycol Med. 2018 Jun;28(2):393-5. DOI: 10.1016&#47;j.mycmed.2018.04.001</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.mycmed.2018.04.001</RefLink>
      </Reference>
      <Reference refNo="15">
        <RefAuthor>Wang CH</RefAuthor>
        <RefAuthor>Hsueh PR</RefAuthor>
        <RefAuthor>Chen FL</RefAuthor>
        <RefAuthor>Lee WS</RefAuthor>
        <RefTitle>Breakthrough fungemia caused by Rhodotorula mucilaginosa during anidulafungin therapy</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>J Microbiol Immunol Infect</RefJournal>
        <RefPage>674-75</RefPage>
        <RefTotal>Wang CH, Hsueh PR, Chen FL, Lee WS. Breakthrough fungemia caused by Rhodotorula mucilaginosa during anidulafungin therapy. J Microbiol Immunol Infect. 2019 Aug;52(4):674-75. DOI: 10.1016&#47;j.jmii.2018.01.001</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jmii.2018.01.001</RefLink>
      </Reference>
      <Reference refNo="16">
        <RefAuthor>Damasceno JL</RefAuthor>
        <RefAuthor>Dos Santos RA</RefAuthor>
        <RefAuthor>Barbosa AH</RefAuthor>
        <RefAuthor>Casemiro LA</RefAuthor>
        <RefAuthor>Pires RH</RefAuthor>
        <RefAuthor>Martins CHG</RefAuthor>
        <RefTitle>Risk of Fungal Infection to Dental Patients</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>ScientificWorldJournal</RefJournal>
        <RefPage>2982478</RefPage>
        <RefTotal>Damasceno JL, Dos Santos RA, Barbosa AH, Casemiro LA, Pires RH, Martins CHG. Risk of Fungal Infection to Dental Patients. ScientificWorldJournal. 2017;2017:2982478. DOI: 10.1155&#47;2017&#47;2982478</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2017&#47;2982478</RefLink>
      </Reference>
      <Reference refNo="17">
        <RefAuthor>Nunes JM</RefAuthor>
        <RefAuthor>Bizerra FC</RefAuthor>
        <RefAuthor>Ferreira RC</RefAuthor>
        <RefAuthor>Colombo AL</RefAuthor>
        <RefTitle>Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Antimicrob Agents Chemother</RefJournal>
        <RefPage>382-9</RefPage>
        <RefTotal>Nunes JM, Bizerra FC, Ferreira RC, Colombo AL. Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother. 2013 Jan;57(1):382-9. DOI: 10.1128&#47;AAC.01647-12</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1128&#47;AAC.01647-12</RefLink>
      </Reference>
      <Reference refNo="18">
        <RefAuthor>Strausbaugh LJ</RefAuthor>
        <RefAuthor>Sewell DL</RefAuthor>
        <RefAuthor>Tjoelker RC</RefAuthor>
        <RefAuthor>Heitzman T</RefAuthor>
        <RefAuthor>Webster T</RefAuthor>
        <RefAuthor>Ward TT</RefAuthor>
        <RefAuthor>Pfaller MA</RefAuthor>
        <RefTitle>Comparison of three methods for recovery of yeasts from hands of health-care workers</RefTitle>
        <RefYear>1996</RefYear>
        <RefJournal>J Clin Microbiol</RefJournal>
        <RefPage>471-3</RefPage>
        <RefTotal>Strausbaugh LJ, Sewell DL, Tjoelker RC, Heitzman T, Webster T, Ward TT, Pfaller MA. Comparison of three methods for recovery of yeasts from hands of health-care workers. J Clin Microbiol. 1996 Feb;34(2):471-3.</RefTotal>
      </Reference>
      <Reference refNo="20">
        <RefAuthor>Guinan J</RefAuthor>
        <RefAuthor>Villa P</RefAuthor>
        <RefAuthor>Thangamani S</RefAuthor>
        <RefTitle>Secondary bile acids inhibit Candida albicans growth and morphogenesis</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Pathog Dis</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Guinan J, Villa P, Thangamani S. Secondary bile acids inhibit Candida albicans growth and morphogenesis. Pathog Dis. 2018 04;76(3). DOI: 10.1093&#47;femspd&#47;fty038</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1093&#47;femspd&#47;fty038</RefLink>
      </Reference>
      <Reference refNo="21">
        <RefAuthor>Spader TB</RefAuthor>
        <RefAuthor>Ram&#237;rez-Castrill&#243;n M</RefAuthor>
        <RefAuthor>Valente P</RefAuthor>
        <RefAuthor>Alves SH</RefAuthor>
        <RefAuthor>Severo LC</RefAuthor>
        <RefTitle>In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Mycopathologia</RefJournal>
        <RefPage>35-43</RefPage>
        <RefTotal>Spader TB, Ram&#237;rez-Castrill&#243;n M, Valente P, Alves SH, Severo LC. In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains. Mycopathologia. 2019 Feb;184(1):35-43. DOI: 10.1007&#47;s11046-019-0317-6</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s11046-019-0317-6</RefLink>
      </Reference>
      <Reference refNo="22">
        <RefAuthor>Zaas AK</RefAuthor>
        <RefAuthor>Boyce M</RefAuthor>
        <RefAuthor>Schell W</RefAuthor>
        <RefAuthor>Lodge BA</RefAuthor>
        <RefAuthor>Miller JL</RefAuthor>
        <RefAuthor>Perfect JR</RefAuthor>
        <RefTitle>Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>J Clin Microbiol</RefJournal>
        <RefPage>5233-5</RefPage>
        <RefTotal>Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol. 2003 Nov;41(11):5233-5. DOI: 10.1128&#47;jcm.41.11.5233-5235.2003</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1128&#47;jcm.41.11.5233-5235.2003</RefLink>
      </Reference>
      <Reference refNo="23">
        <RefAuthor>Diekema DJ</RefAuthor>
        <RefAuthor>Petroelje B</RefAuthor>
        <RefAuthor>Messer SA</RefAuthor>
        <RefAuthor>Hollis RJ</RefAuthor>
        <RefAuthor>Pfaller MA</RefAuthor>
        <RefTitle>Activities of available and investigational antifungal agents against rhodotorula species</RefTitle>
        <RefYear>2005</RefYear>
        <RefJournal>J Clin Microbiol</RefJournal>
        <RefPage>476-8</RefPage>
        <RefTotal>Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. Activities of available and investigational antifungal agents against rhodotorula species. J Clin Microbiol. 2005 Jan;43(1):476-8. DOI: 10.1128&#47;JCM.43.1.476-478.2005</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1128&#47;JCM.43.1.476-478.2005</RefLink>
      </Reference>
      <Reference refNo="24">
        <RefAuthor>Falces-Romero I</RefAuthor>
        <RefAuthor>Cendejas-Bueno E</RefAuthor>
        <RefAuthor>Romero-G&#243;mez MP</RefAuthor>
        <RefAuthor>Garc&#237;a-Rodr&#237;guez J</RefAuthor>
        <RefTitle>Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Mycoses</RefJournal>
        <RefPage>35-9</RefPage>
        <RefTotal>Falces-Romero I, Cendejas-Bueno E, Romero-G&#243;mez MP, Garc&#237;a-Rodr&#237;guez J. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital. Mycoses. 2018 Jan;61(1):35-9. DOI: 10.1111&#47;myc.12703</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;myc.12703</RefLink>
      </Reference>
      <Reference refNo="25">
        <RefAuthor>Potenza L</RefAuthor>
        <RefAuthor>Chitasombat MN</RefAuthor>
        <RefAuthor>Klimko N</RefAuthor>
        <RefAuthor>Bettelli F</RefAuthor>
        <RefAuthor>Dragonetti G</RefAuthor>
        <RefAuthor>Del Principe MI</RefAuthor>
        <RefAuthor>Nucci M</RefAuthor>
        <RefAuthor>Busca A</RefAuthor>
        <RefAuthor>Fracchiolla N</RefAuthor>
        <RefAuthor>Scium&#232; M</RefAuthor>
        <RefAuthor>Spolzino A</RefAuthor>
        <RefAuthor>Delia M</RefAuthor>
        <RefAuthor>Mancini V</RefAuthor>
        <RefAuthor>Nadali GP</RefAuthor>
        <RefAuthor>Dargenio M</RefAuthor>
        <RefAuthor>Shadrivova O</RefAuthor>
        <RefAuthor>Bacchelli F</RefAuthor>
        <RefAuthor>Aversa F</RefAuthor>
        <RefAuthor>Sanguinetti M</RefAuthor>
        <RefAuthor>Luppi M</RefAuthor>
        <RefAuthor>Kontoyiannis DP</RefAuthor>
        <RefAuthor>Pagano L</RefAuthor>
        <RefTitle>Rhodotorula infection in haematological patient: Risk factors and outcome</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Mycoses</RefJournal>
        <RefPage>223-9</RefPage>
        <RefTotal>Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Scium&#232; M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L. Rhodotorula infection in haematological patient: Risk factors and outcome. Mycoses. 2019 Mar;62(3):223-9. DOI: 10.1111&#47;myc.12875</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;myc.12875</RefLink>
      </Reference>
      <Reference refNo="26">
        <RefAuthor>Kolouchov&#225; I</RefAuthor>
        <RefAuthor>Schreiberov&#225; O</RefAuthor>
        <RefAuthor>Sigler K</RefAuthor>
        <RefAuthor>Mas&#225;k J</RefAuthor>
        <RefAuthor>&#344;ezanka T</RefAuthor>
        <RefTitle>Biotransformation of volatile fatty acids by oleaginous and non-oleaginous yeast species</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>FEMS Yeast Res</RefJournal>
        <RefArticleNo>fov076</RefArticleNo>
        <RefTotal>Kolouchov&#225; I, Schreiberov&#225; O, Sigler K, Mas&#225;k J, &#344;ezanka T. Biotransformation of volatile fatty acids by oleaginous and non-oleaginous yeast species. FEMS Yeast Res. 2015 Nov;15(7). pii: fov076. DOI: 10.1093&#47;femsyr&#47;fov076</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1093&#47;femsyr&#47;fov076</RefLink>
      </Reference>
      <Reference refNo="27">
        <RefAuthor>Marzocco S</RefAuthor>
        <RefAuthor>Fazeli G</RefAuthor>
        <RefAuthor>Di Micco L</RefAuthor>
        <RefAuthor>Autore G</RefAuthor>
        <RefAuthor>Adesso S</RefAuthor>
        <RefAuthor>Dal Piaz F</RefAuthor>
        <RefAuthor>Heidland A</RefAuthor>
        <RefAuthor>Di Iorio B</RefAuthor>
        <RefTitle>Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study)</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>J Clin Med</RefJournal>
        <RefArticleNo>E315</RefArticleNo>
        <RefTotal>Marzocco S, Fazeli G, Di Micco L, Autore G, Adesso S, Dal Piaz F, Heidland A, Di Iorio B. Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study). J Clin Med. 2018 09;7(10). pii: E315. DOI: 10.3390&#47;jcm7100315</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;jcm7100315</RefLink>
      </Reference>
      <Reference refNo="28">
        <RefAuthor>Volkheimer G</RefAuthor>
        <RefTitle>Das Ph&#228;nomen der Persorption--Historie und Fakten</RefTitle>
        <RefYear>1993</RefYear>
        <RefJournal>Z Arztl Fortbild (Jena)</RefJournal>
        <RefPage>217-21</RefPage>
        <RefTotal>Volkheimer G. Das Ph&#228;nomen der Persorption--Historie und Fakten &#91;The phenomenon of persorption--history and facts&#93;. Z Arztl Fortbild (Jena). 1993 Mar;87(3):217-21.</RefTotal>
      </Reference>
      <Reference refNo="29">
        <RefAuthor>Assimakopoulos SF</RefAuthor>
        <RefAuthor>Triantos C</RefAuthor>
        <RefAuthor>Thomopoulos K</RefAuthor>
        <RefAuthor>Fligou F</RefAuthor>
        <RefAuthor>Maroulis I</RefAuthor>
        <RefAuthor>Marangos M</RefAuthor>
        <RefAuthor>Gogos CA</RefAuthor>
        <RefTitle>Gut-origin sepsis in the critically ill patient: pathophysiology and treatment</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Infection</RefJournal>
        <RefPage>751-60</RefPage>
        <RefTotal>Assimakopoulos SF, Triantos C, Thomopoulos K, Fligou F, Maroulis I, Marangos M, Gogos CA. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018 Dec;46(6):751-60. DOI: 10.1007&#47;s15010-018-1178-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s15010-018-1178-5</RefLink>
      </Reference>
      <Reference refNo="30">
        <RefAuthor>Assimakopoulos SF</RefAuthor>
        <RefAuthor>Triantos C</RefAuthor>
        <RefAuthor>Maroulis I</RefAuthor>
        <RefAuthor>Gogos C</RefAuthor>
        <RefTitle>The Role of the Gut Barrier Function in Health and Disease</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Gastroenterology Res</RefJournal>
        <RefPage>261-3</RefPage>
        <RefTotal>Assimakopoulos SF, Triantos C, Maroulis I, Gogos C. The Role of the Gut Barrier Function in Health and Disease. Gastroenterology Res. 2018 Aug;11(4):261-3. DOI: 10.14740&#47;gr1053w</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.14740&#47;gr1053w</RefLink>
      </Reference>
      <Reference refNo="31">
        <RefAuthor>Sedman PC</RefAuthor>
        <RefAuthor>Macfie J</RefAuthor>
        <RefAuthor>Sagar P</RefAuthor>
        <RefAuthor>Mitchell CJ</RefAuthor>
        <RefAuthor>May J</RefAuthor>
        <RefAuthor>Mancey-Jones B</RefAuthor>
        <RefAuthor>Johnstone D</RefAuthor>
        <RefTitle>The prevalence of gut translocation in humans</RefTitle>
        <RefYear>1994</RefYear>
        <RefJournal>Gastroenterology</RefJournal>
        <RefPage>643-9</RefPage>
        <RefTotal>Sedman PC, Macfie J, Sagar P, Mitchell CJ, May J, Mancey-Jones B, Johnstone D. The prevalence of gut translocation in humans. Gastroenterology. 1994 Sep;107(3):643-9. DOI: 10.1016&#47;0016-5085(94)90110-4</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;0016-5085(94)90110-4</RefLink>
      </Reference>
      <Reference refNo="32">
        <RefAuthor>Chiaro TR</RefAuthor>
        <RefAuthor>Soto R</RefAuthor>
        <RefAuthor>Zac Stephens W</RefAuthor>
        <RefAuthor>Kubinak JL</RefAuthor>
        <RefAuthor>Petersen C</RefAuthor>
        <RefAuthor>Gogokhia L</RefAuthor>
        <RefAuthor>Bell R</RefAuthor>
        <RefAuthor>Delgado JC</RefAuthor>
        <RefAuthor>Cox J</RefAuthor>
        <RefAuthor>Voth W</RefAuthor>
        <RefAuthor>Brown J</RefAuthor>
        <RefAuthor>Stillman DJ</RefAuthor>
        <RefAuthor>O&#39;Connell RM</RefAuthor>
        <RefAuthor>Tebo AE</RefAuthor>
        <RefAuthor>Round JL</RefAuthor>
        <RefTitle>A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Sci Transl Med</RefJournal>
        <RefArticleNo>eaaf9044</RefArticleNo>
        <RefTotal>Chiaro TR, Soto R, Zac Stephens W, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W, Brown J, Stillman DJ, O&#39;Connell RM, Tebo AE, Round JL. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med. 2017 03;9(380). pii: eaaf9044. DOI: 10.1126&#47;scitranslmed.aaf9044</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1126&#47;scitranslmed.aaf9044</RefLink>
      </Reference>
      <Reference refNo="33">
        <RefAuthor>Vaishnavi C</RefAuthor>
        <RefTitle>Translocation of gut flora and its role in sepsis</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Indian J Med Microbiol</RefJournal>
        <RefPage>334-42</RefPage>
        <RefTotal>Vaishnavi C. Translocation of gut flora and its role in sepsis. Indian J Med Microbiol. 2013 Oct-Dec;31(4):334-42. DOI: 10.4103&#47;0255-0857.118870</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.4103&#47;0255-0857.118870</RefLink>
      </Reference>
      <Reference refNo="34">
        <RefAuthor>Wiest R</RefAuthor>
        <RefAuthor>Lawson M</RefAuthor>
        <RefAuthor>Geuking M</RefAuthor>
        <RefTitle>Pathological bacterial translocation in liver cirrhosis</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>J Hepatol</RefJournal>
        <RefPage>197-209</RefPage>
        <RefTotal>Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014 Jan;60(1):197-209. DOI: 10.1016&#47;j.jhep.2013.07.044</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jhep.2013.07.044</RefLink>
      </Reference>
      <Reference refNo="35">
        <RefAuthor>Yamaguchi N</RefAuthor>
        <RefAuthor>Sugita R</RefAuthor>
        <RefAuthor>Miki A</RefAuthor>
        <RefAuthor>Takemura N</RefAuthor>
        <RefAuthor>Kawabata J</RefAuthor>
        <RefAuthor>Watanabe J</RefAuthor>
        <RefAuthor>Sonoyama K</RefAuthor>
        <RefTitle>Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Gut</RefJournal>
        <RefPage>954-60</RefPage>
        <RefTotal>Yamaguchi N, Sugita R, Miki A, Takemura N, Kawabata J, Watanabe J, Sonoyama K. Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice. Gut. 2006 Jul;55(7):954-60. DOI: 10.1136&#47;gut.2005.084954</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1136&#47;gut.2005.084954</RefLink>
      </Reference>
      <Reference refNo="36">
        <RefAuthor>Schulze J</RefAuthor>
        <RefAuthor>Sonnenborn U</RefAuthor>
        <RefTitle>Yeasts in the gut: from commensals to infectious agents</RefTitle>
        <RefYear>2009</RefYear>
        <RefJournal>Dtsch Arztebl Int</RefJournal>
        <RefPage>837-42</RefPage>
        <RefTotal>Schulze J, Sonnenborn U. Yeasts in the gut: from commensals to infectious agents. Dtsch Arztebl Int. 2009 Dec;106(51-52):837-42. DOI: 10.3238&#47;arztebl.2009.0837</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3238&#47;arztebl.2009.0837</RefLink>
      </Reference>
      <Reference refNo="37">
        <RefAuthor>Hoffmann C</RefAuthor>
        <RefAuthor>Dollive S</RefAuthor>
        <RefAuthor>Grunberg S</RefAuthor>
        <RefAuthor>Chen J</RefAuthor>
        <RefAuthor>Li H</RefAuthor>
        <RefAuthor>Wu GD</RefAuthor>
        <RefAuthor>Lewis JD</RefAuthor>
        <RefAuthor>Bushman FD</RefAuthor>
        <RefTitle>Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>PLoS ONE</RefJournal>
        <RefPage>e66019</RefPage>
        <RefTotal>Hoffmann C, Dollive S, Grunberg S, Chen J, Li H, Wu GD, Lewis JD, Bushman FD. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE. 2013;8(6):e66019. DOI: 10.1371&#47;journal.pone.0066019</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1371&#47;journal.pone.0066019</RefLink>
      </Reference>
      <Reference refNo="38">
        <RefAuthor>Wheeler ML</RefAuthor>
        <RefAuthor>Limon JJ</RefAuthor>
        <RefAuthor>Bar AS</RefAuthor>
        <RefAuthor>Leal CA</RefAuthor>
        <RefAuthor>Gargus M</RefAuthor>
        <RefAuthor>Tang J</RefAuthor>
        <RefAuthor>Brown J</RefAuthor>
        <RefAuthor>Funari VA</RefAuthor>
        <RefAuthor>Wang HL</RefAuthor>
        <RefAuthor>Crother TR</RefAuthor>
        <RefAuthor>Arditi M</RefAuthor>
        <RefAuthor>Underhill DM</RefAuthor>
        <RefAuthor>Iliev ID</RefAuthor>
        <RefTitle>Immunological Consequences of Intestinal Fungal Dysbiosis</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Cell Host Microbe</RefJournal>
        <RefPage>865-73</RefPage>
        <RefTotal>Wheeler ML, Limon JJ, Bar AS, Leal CA, Gargus M, Tang J, Brown J, Funari VA, Wang HL, Crother TR, Arditi M, Underhill DM, Iliev ID. Immunological Consequences of Intestinal Fungal Dysbiosis. Cell Host Microbe. 2016 Jun;19(6):865-73. DOI: 10.1016&#47;j.chom.2016.05.003</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.chom.2016.05.003</RefLink>
      </Reference>
      <Reference refNo="39">
        <RefAuthor>Korhola M</RefAuthor>
        <RefAuthor>Hakonen R</RefAuthor>
        <RefAuthor>Juuti K</RefAuthor>
        <RefAuthor>Edelmann M</RefAuthor>
        <RefAuthor>Kariluoto S</RefAuthor>
        <RefAuthor>Nystr&#246;m L</RefAuthor>
        <RefAuthor>Sontag-Strohm T</RefAuthor>
        <RefAuthor>Piironen V</RefAuthor>
        <RefTitle>Production of folate in oat bran fermentation by yeasts isolated from barley and diverse foods</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>J Appl Microbiol</RefJournal>
        <RefPage>679-89</RefPage>
        <RefTotal>Korhola M, Hakonen R, Juuti K, Edelmann M, Kariluoto S, Nystr&#246;m L, Sontag-Strohm T, Piironen V. Production of folate in oat bran fermentation by yeasts isolated from barley and diverse foods. J Appl Microbiol. 2014 Sep;117(3):679-89. DOI: 10.1111&#47;jam.12564</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;jam.12564</RefLink>
      </Reference>
      <Reference refNo="40">
        <RefAuthor>Limon JJ</RefAuthor>
        <RefAuthor>Skalski JH</RefAuthor>
        <RefAuthor>Underhill DM</RefAuthor>
        <RefTitle>Commensal Fungi in Health and Disease</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Cell Host Microbe</RefJournal>
        <RefPage>156-65</RefPage>
        <RefTotal>Limon JJ, Skalski JH, Underhill DM. Commensal Fungi in Health and Disease. Cell Host Microbe. 2017 Aug;22(2):156-65. DOI: 10.1016&#47;j.chom.2017.07.002</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.chom.2017.07.002</RefLink>
      </Reference>
      <Reference refNo="41">
        <RefAuthor>Just S</RefAuthor>
        <RefAuthor>Mondot S</RefAuthor>
        <RefAuthor>Ecker J</RefAuthor>
        <RefAuthor>Wegner K</RefAuthor>
        <RefAuthor>Rath E</RefAuthor>
        <RefAuthor>Gau L</RefAuthor>
        <RefAuthor>Streidl T</RefAuthor>
        <RefAuthor>Hery-Arnaud G</RefAuthor>
        <RefAuthor>Schmidt S</RefAuthor>
        <RefAuthor>Lesker TR</RefAuthor>
        <RefAuthor>Bieth V</RefAuthor>
        <RefAuthor>Dunkel A</RefAuthor>
        <RefAuthor>Strowig T</RefAuthor>
        <RefAuthor>Hofmann T</RefAuthor>
        <RefAuthor>Haller D</RefAuthor>
        <RefAuthor>Liebisch G</RefAuthor>
        <RefAuthor>G&#233;rard P</RefAuthor>
        <RefAuthor>Rohn S</RefAuthor>
        <RefAuthor>Lepage P</RefAuthor>
        <RefAuthor>Clavel T</RefAuthor>
        <RefTitle>The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Microbiome</RefJournal>
        <RefPage>134</RefPage>
        <RefTotal>Just S, Mondot S, Ecker J, Wegner K, Rath E, Gau L, Streidl T, Hery-Arnaud G, Schmidt S, Lesker TR, Bieth V, Dunkel A, Strowig T, Hofmann T, Haller D, Liebisch G, G&#233;rard P, Rohn S, Lepage P, Clavel T. The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism. Microbiome. 2018 08;6(1):134. DOI: 10.1186&#47;s40168-018-0510-8</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s40168-018-0510-8</RefLink>
      </Reference>
      <Reference refNo="42">
        <RefAuthor>Hof H</RefAuthor>
        <RefTitle>Vitamin A, das &#8222;anti-infektive&#8220; Vitamin</RefTitle>
        <RefYear>1976</RefYear>
        <RefJournal>MMW Munch Med Wochenschr</RefJournal>
        <RefPage>1485-8</RefPage>
        <RefTotal>Hof H. Vitamin A, das &#8222;anti-infektive&#8220; Vitamin &#91;Vitamin A, the &#8220;anti-infective&#8220; vitamin&#63; (author&#8217;s transl)&#93;. MMW Munch Med Wochenschr. 1976 Nov;118(46):1485-8.</RefTotal>
      </Reference>
      <Reference refNo="43">
        <RefAuthor>Fei Z</RefAuthor>
        <RefAuthor>Li S</RefAuthor>
        <RefAuthor>Wang J</RefAuthor>
        <RefAuthor>Wang Y</RefAuthor>
        <RefAuthor>Jiang Z</RefAuthor>
        <RefAuthor>Huang W</RefAuthor>
        <RefAuthor>Sun H</RefAuthor>
        <RefTitle>Rhodotorula glutinis as a living cell liposome to deliver polypeptide drugs in vivo</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Drug Deliv</RefJournal>
        <RefPage>51-62</RefPage>
        <RefTotal>Fei Z, Li S, Wang J, Wang Y, Jiang Z, Huang W, Sun H. Rhodotorula glutinis as a living cell liposome to deliver polypeptide drugs in vivo. Drug Deliv. 2019 Dec;26(1):51-62. DOI: 10.1080&#47;10717544.2018.1551439</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1080&#47;10717544.2018.1551439</RefLink>
      </Reference>
      <Reference refNo="44">
        <RefAuthor>Iliev ID</RefAuthor>
        <RefAuthor>Underhill DM</RefAuthor>
        <RefTitle>Striking a balance: fungal commensalism versus pathogenesis</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Curr Opin Microbiol</RefJournal>
        <RefPage>366-73</RefPage>
        <RefTotal>Iliev ID, Underhill DM. Striking a balance: fungal commensalism versus pathogenesis. Curr Opin Microbiol. 2013 Jun;16(3):366-73. DOI: 10.1016&#47;j.mib.2013.05.004</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.mib.2013.05.004</RefLink>
      </Reference>
      <Reference refNo="45">
        <RefAuthor>Mor&#233; MI</RefAuthor>
        <RefAuthor>Swidsinski A</RefAuthor>
        <RefTitle>Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Clin Exp Gastroenterol</RefJournal>
        <RefPage>237-55</RefPage>
        <RefTotal>Mor&#233; MI, Swidsinski A. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. Clin Exp Gastroenterol. 2015;8:237-55. DOI: 10.2147&#47;CEG.S85574</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2147&#47;CEG.S85574</RefLink>
      </Reference>
      <Reference refNo="46">
        <RefAuthor>Gedek BR</RefAuthor>
        <RefTitle>Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii</RefTitle>
        <RefYear>1999</RefYear>
        <RefJournal>Mycoses</RefJournal>
        <RefPage>261-4</RefPage>
        <RefTotal>Gedek BR. Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses. 1999;42(4):261-4.</RefTotal>
      </Reference>
      <Reference refNo="47">
        <RefAuthor>Tiago FC</RefAuthor>
        <RefAuthor>Martins FS</RefAuthor>
        <RefAuthor>Souza EL</RefAuthor>
        <RefAuthor>Pimenta PF</RefAuthor>
        <RefAuthor>Araujo HR</RefAuthor>
        <RefAuthor>Castro IM</RefAuthor>
        <RefAuthor>Brand&#227;o RL</RefAuthor>
        <RefAuthor>Nicoli JR</RefAuthor>
        <RefTitle>Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>J Med Microbiol</RefJournal>
        <RefPage>1194-207</RefPage>
        <RefTotal>Tiago FC, Martins FS, Souza EL, Pimenta PF, Araujo HR, Castro IM, Brand&#227;o RL, Nicoli JR. Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J Med Microbiol. 2012 Sep;61(Pt 9):1194-207. DOI: 10.1099&#47;jmm.0.042283-0</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1099&#47;jmm.0.042283-0</RefLink>
      </Reference>
      <Reference refNo="48">
        <RefAuthor>Trenschel R</RefAuthor>
        <RefAuthor>Peceny R</RefAuthor>
        <RefAuthor>Runde V</RefAuthor>
        <RefAuthor>Elmaagacli A</RefAuthor>
        <RefAuthor>Dermoumi H</RefAuthor>
        <RefAuthor>Heintschel von Heinegg E</RefAuthor>
        <RefAuthor>M&#252;ller KD</RefAuthor>
        <RefAuthor>Schaefer UW</RefAuthor>
        <RefAuthor>Beelen DW</RefAuthor>
        <RefTitle>Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination</RefTitle>
        <RefYear>2000</RefYear>
        <RefJournal>Bone Marrow Transplant</RefJournal>
        <RefPage>993-7</RefPage>
        <RefTotal>Trenschel R, Peceny R, Runde V, Elmaagacli A, Dermoumi H, Heintschel von Heinegg E, M&#252;ller KD, Schaefer UW, Beelen DW. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplant. 2000 Nov;26(9):993-7. DOI: 10.1038&#47;sj.bmt.1702655</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;sj.bmt.1702655</RefLink>
      </Reference>
      <Reference refNo="51">
        <RefAuthor>Thomson P</RefAuthor>
        <RefAuthor>L&#243;pez-Fern&#225;ndez L</RefAuthor>
        <RefAuthor>Guarro J</RefAuthor>
        <RefAuthor>Capilla J</RefAuthor>
        <RefTitle>Virulence and antifungal therapy of murine disseminated infection by Rhodotorula mucilaginosa</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Diagn Microbiol Infect Dis</RefJournal>
        <RefPage>47-51</RefPage>
        <RefTotal>Thomson P, L&#243;pez-Fern&#225;ndez L, Guarro J, Capilla J. Virulence and antifungal therapy of murine disseminated infection by Rhodotorula mucilaginosa. Diagn Microbiol Infect Dis. 2017 Sep;89(1):47-51. DOI: 10.1016&#47;j.diagmicrobio.2017.06.005</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.diagmicrobio.2017.06.005</RefLink>
      </Reference>
      <Reference refNo="49">
        <RefAuthor>Suhr MJ</RefAuthor>
        <RefAuthor>Hallen-Adams HE</RefAuthor>
        <RefTitle>The human gut mycobiome: pitfalls and potentials &#8211; a mycologist&#8217;s perspective</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Mycologia</RefJournal>
        <RefPage>1057-73</RefPage>
        <RefTotal>Suhr MJ, Hallen-Adams HE. The human gut mycobiome: pitfalls and potentials &#8211; a mycologist&#8217;s perspective. Mycologia. 2015 Nov-Dec;107(6):1057-73. DOI: 10.3852&#47;15-147</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3852&#47;15-147</RefLink>
      </Reference>
      <Reference refNo="50">
        <RefAuthor>Jankowski M</RefAuthor>
        <RefAuthor>Charemska A</RefAuthor>
        <RefAuthor>Czajkowski R</RefAuthor>
        <RefTitle>Swimming pools and fungi: An epidemiology survey in Polish indoor swimming facilities</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Mycoses</RefJournal>
        <RefPage>736-8</RefPage>
        <RefTotal>Jankowski M, Charemska A, Czajkowski R. Swimming pools and fungi: An epidemiology survey in Polish indoor swimming facilities. Mycoses. 2017 Nov;60(11):736-8. DOI: 10.1111&#47;myc.12654</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;myc.12654</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <Table format="png">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption><Pgraph><Mark1>Table 1: Antimicrobial susceptibilities of Rhodotorula spp. (according to &#91;22&#93;)</Mark1></Pgraph></Caption>
        </Table>
        <NoOfTables>1</NoOfTables>
      </Tables>
      <Figures>
        <Figure format="png" height="512" width="536">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption><Pgraph><Mark1>Figure 1: Appearancies of various colonies of Rhodotorula spp. on Sabouraud agar. 5 days after incubation at 30&#176;C. Note the variable colour shades and roughnesses.</Mark1></Pgraph></Caption>
        </Figure>
        <NoOfPictures>1</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>